Novel screening approaches for human prion diseases drug discovery

References

• Prusiner SB. Novel structure and genetics of prions causing neurodegeneration in humans and animals. Biologicals. 1990 Oct;18(4):247–262. PubMed PMID: 1981006.
   PubMed Web of Science ®Google Scholar
• Caughey B. Interactions between prion protein isoforms: the kiss of death? Trends Biochem Sci. 2001 Apr;26(4):235–242. PubMed PMID: 11295556.
   PubMed Web of Science ®Google Scholar
• Stahl N, Borchelt DR, Hsiao K, et al. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell. 1987 Oct 23;51(2):229–240. PubMed PMID: 2444340.
   PubMed Web of Science ®Google Scholar
• Hill AF, Joiner S, Beck JA, et al. Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. Brain. 2006 Mar;129(Pt 3):676–685. PubMed PMID: 16415305.
   PubMedGoogle Scholar
• Pan KM, Baldwin M, Nguyen J, et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A. 1993 Dec 01;90(23):10962–10966. PubMed PMID: 7902575; PubMed Central PMCID: PMCPMC47901.
   PubMed Web of Science ®Google Scholar
• Federspil PA, Federspil P, Plinkert PK. [Diagnosis of prion diseases]. HNO. 2002 Apr;50(4):327–331. PubMed PMID: 12063690.
   PubMed Web of Science ®Google Scholar
• Kubler E, Oesch B, Raeber AJ. Diagnosis of prion diseases. Br Med Bull. 2003;66: 267–279. PubMed PMID: 14522864.
   PubMed Web of Science ®Google Scholar
• Budka H. Neuropathology of prion diseases. Br Med Bull. 2003;66: 121–130. PubMed PMID: 14522854.
   PubMed Web of Science ®Google Scholar
• Gibbs CJ Jr., Gajdusek DC, Asher DM, et al. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science. 1968 Jul 26;161(3839):388–389. PubMed PMID: 5661299.
   PubMed Web of Science ®Google Scholar
• Gambetti P, Kong Q, Zou W, et al. Sporadic and familial CJD: classification and characterisation. Br Med Bull. 2003;66:213–239. PubMed PMID: 14522861
   PubMed Web of Science ®Google Scholar
• Gambetti P, Dong Z, Yuan J, et al. A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol. 2008 Jun;63(6):697–708. PubMed PMID: 18571782; PubMed Central PMCID: PMCPMC2767200.
   PubMed Web of Science ®Google Scholar
• Zou WQ, Puoti G, Xiao X, et al. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol. 2010 Aug;68(2):162–172. PubMed PMID: 20695009; PubMed Central PMCID: PMCPMC3032610.
   PubMed Web of Science ®Google Scholar
• Chen C, Dong XP. Epidemiological characteristics of human prion diseases. Infect Dis Poverty. 2016 Jun 2;5(1):47. 10.1186/s40249-016-0143-8. PubMed PMID: 27251305; PubMed Central PMCID: PMCPMC4890484.
   PubMed Web of Science ®Google Scholar
• Mastrianni JA. The genetics of prion diseases. Genet Med. 2010 Apr;12(4):187–195. PubMed PMID: 20216075. .
   PubMed Web of Science ®Google Scholar
• Hainfellner JA, Parchi P, Kitamoto T, et al. A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein. Ann Neurol. 1999 Jun;45(6):812–816. PubMed PMID: 10360778.
   PubMed Web of Science ®Google Scholar
• Medori R, Tritschler HJ, LeBlanc A, et al. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med. 1992 Feb 13;326(7):444–449. PubMed PMID: 1346338; PubMed Central PMCID: PMCPMC6151859.
   PubMed Web of Science ®Google Scholar
• Young K, Clark HB, Piccardo P, et al. Gerstmann-Straussler-Scheinker disease with the PRNP P102L mutation and valine at codon 129. Brain Res Mol Brain Res. 1997 Feb;44(1):147–150. PubMed PMID: 9030710.
   PubMedGoogle Scholar
• Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature. 1997 Oct 02;389(6650):498–501. PubMed PMID: 9333239.
   PubMed Web of Science ®Google Scholar
• Bougard D, Brandel JP, Belondrade M, et al. Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease. Sci Transl Med. 2016 Dec 21;8(370):370ra182. PubMed PMID: 28003547.
   PubMed Web of Science ®Google Scholar
• Lacroux C, Comoy E, Moudjou M, et al. Preclinical detection of variant CJD and BSE prions in blood. PLoS Pathog. 2014 Jun;10(6):e1004202. PubMed PMID: 24945656; PubMed Central PMCID: PMCPMC4055790.
   PubMed Web of Science ®Google Scholar
• Boelle PY, Valleron AJ. Incubation period of human prion disease. Lancet. 2006 Sep 9;368(9539):914; author reply 914–5. PubMed PMID: 16962872.
   PubMedGoogle Scholar
• Soto C, Castilla J. The controversial protein-only hypothesis of prion propagation. Nat Med. 2004 Jul;10 Suppl:S63–7. PubMed PMID: 15272271.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Chien P, Naber N, et al. Conformational variations in an infectious protein determine prion strain differences. Nature. 2004 Mar 18;428(6980):323–328. PubMed PMID: 15029196.
   PubMed Web of Science ®Google Scholar
• Nelson R, Eisenberg D. Structural models of amyloid-like fibrils. Adv Protein Chem. 2006;73:235–282. PubMed PMID: 17190616.
   PubMedGoogle Scholar
• Tanaka M, Collins SR, Toyama BH, et al. The physical basis of how prion conformations determine strain phenotypes. Nature. 2006 Aug 3;442(7102):585–589. PubMed PMID: 16810177.
   PubMed Web of Science ®Google Scholar
• Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science. 2007 Nov 9;318(5852):930–936. PubMed PMID: 17991853.
   PubMed Web of Science ®Google Scholar
• Safar J, Wille H, Itri V, et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med. 1998 Oct;4(10):1157–1165. PubMed PMID: 9771749.
   PubMed Web of Science ®Google Scholar
• Weissmann C. Thoughts on mammalian prion strains. Folia Neuropathol. 2009;47(2): 104–113. PubMed PMID: 19618334.
   PubMed Web of Science ®Google Scholar
• Bessen RA, Marsh RF. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol. 1992 Apr;66(4):2096–2101. PubMed PMID: 1347795; PubMed Central PMCID: PMCPMC289000.
   PubMed Web of Science ®Google Scholar
• Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 1996 Jun;39(6):767–778. PubMed PMID: 8651649.
   PubMed Web of Science ®Google Scholar
• Khalili-Shirazi A, Summers L, Linehan J, et al. PrP glycoforms are associated in a strain-specific ratio in native PrPSc. J Gen Virol. 2005 Sep;86(Pt 9):2635–2644. PubMed PMID: 16099923.
   PubMedGoogle Scholar
• Caughey B, Raymond GJ, Bessen RA. Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J Biol Chem. 1998 Nov 27;273(48):32230–32235. PubMed PMID: 9822701.
   PubMed Web of Science ®Google Scholar
• Bellon A, Seyfert-Brandt W, Lang W, et al. Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity. J Gen Virol. 2003 Jul;84(Pt 7):1921–1925. PubMed PMID: 12810888.
   PubMedGoogle Scholar
• Jones EM, Surewicz WK. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell. 2005 Apr 8;121(1):63–72. PubMed PMID: 15820679
   PubMed Web of Science ®Google Scholar
• Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999 Aug;46(2):224–233. PubMed PMID: 10443888.
   PubMed Web of Science ®Google Scholar
• Hill AF, Joiner S, Wadsworth JD, et al. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain. 2003 Jun;126(Pt 6):1333–1346. PubMed PMID: 12764055.
   PubMed Web of Science ®Google Scholar
• Parchi P, Strammiello R, Notari S, et al. Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol. 2009 Nov;118(5):659–671. PubMed PMID: 19718500; PubMed Central PMCID: PMCPMC2773124.
   PubMed Web of Science ®Google Scholar
• Lewis PA, Tattum MH, Jones S, et al. Codon 129 polymorphism of the human prion protein influences the kinetics of amyloid formation. J Gen Virol. 2006 Aug;87(Pt 8):2443–2449. PubMed PMID: 16847141.
   PubMedGoogle Scholar
• Goldfarb LG, Petersen RB, Tabaton M, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science. 1992 Oct 30;258(5083):806–808. PubMed PMID: 1439789.
   PubMed Web of Science ®Google Scholar
• Gambetti P, Puoti G, Zou WQ. Variably protease-sensitive prionopathy: a novel disease of the prion protein. J Mol Neurosci. 2011 Nov;45(3):422–424. PubMed PMID: 21584652.
   PubMed Web of Science ®Google Scholar
• Hill AF, Desbruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE. Nature. 1997 Oct 02;389(6650):448–50, 526. PubMed PMID: 9333232.
   PubMed Web of Science ®Google Scholar
• Telling GC, Parchi P, DeArmond SJ, et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science. 1996 Dec 20;274(5295):2079–2082. PubMed PMID: 8953038.
   PubMed Web of Science ®Google Scholar
• Tsuboi Y, Doh-Ura K, Yamada T. Continuous intraventricular infusion of pentosan polysulfate: clinical trial against prion diseases. Neuropathology. 2009 Oct;29(5):632–636. PubMed PMID: 19788637.
   PubMed Web of Science ®Google Scholar
• Doh-ura K, Ishikawa K, Murakami-Kubo I, et al. Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models. J Virol. 2004 May;78(10):4999–5006. PubMed PMID: 15113880; PubMed Central PMCID: PMCPMC400350.
   PubMed Web of Science ®Google Scholar
• Murakami-Kubo I, Doh-Ura K, Ishikawa K, et al. Quinoline derivatives are therapeutic candidates for transmissible spongiform encephalopathies. J Virol. 2004 Feb;78(3):1281–1288. PubMed PMID: 14722283; PubMed Central PMCID: PMCPMC327112.
   PubMed Web of Science ®Google Scholar
• Korth C, May BC, Cohen FE, et al. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9836–9841. PubMed PMID: 11504948; PubMed Central PMCID: PMCPMC55539.
   PubMed Web of Science ®Google Scholar
• Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci. 2001;24:519–550. PubMed PMID: 11283320.
   PubMed Web of Science ®Google Scholar
• Priola SA. Prion protein and species barriers in the transmissible spongiform encephalopathies. Biomed Pharmacother. 1999;53(1): 27–33. PubMed PMID: 10221165.
   PubMed Web of Science ®Google Scholar
• Panegyres PK, Armari E. Therapies for human prion diseases. Am J Neurodegener Dis. 2013 Sep 18;2(3):176–186. PubMed PMID: 24093082; PubMed Central PMCID: PMCPMC3783831.
   PubMedGoogle Scholar
• Forloni G, Roiter I, Tagliavini F. Clinical trials of prion disease therapeutics. Curr Opin Pharmacol. 2019 May 17;44:53–60.
   PubMed Web of Science ®Google Scholar
• Haik S, Marcon G, Mallet A, et al. Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2014 Feb;13(2):150–158. PubMed PMID: 24411709.
   PubMed Web of Science ®Google Scholar
• Brandner S, Jaunmuktane Z. Prion disease: experimental models and reality. Acta Neuropathol. 2017 Feb;133(2):197–222. 10.1007/s00401-017-1670-5. PubMed PMID: 28084518; PubMed Central PMCID: PMCPMC5250673.
   PubMed Web of Science ®Google Scholar
• Herrmann US, Schutz AK, Shirani H, et al. Structure-based drug design identifies polythiophenes as antiprion compounds. Sci Transl Med. 2015 Aug 5;7(299):299ra123. PubMed PMID: 26246168.
   PubMed Web of Science ®Google Scholar
• Berry DB, Lu D, Geva M, et al. Drug resistance confounding prion therapeutics. Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):E4160–9. PubMed PMID: 24128760; PubMed Central PMCID: PMCPMC3816483.
   PubMed Web of Science ®Google Scholar
• Collinge J. Mammalian prions and their wider relevance in neurodegenerative diseases. Nature. 2016 Nov 10;539(7628):217–226. PubMed PMID: 27830781.
   PubMed Web of Science ®Google Scholar
• Moore RA, Vorberg I, Priola SA. Species barriers in prion diseases–brief review. Arch Virol Suppl. 2005;(19):187–202. PubMed PMID: 16355873.
   PubMedGoogle Scholar
• Hill AF, Collinge J. Prion strains and species barriers. Contrib Microbiol. 2004;11: 33–49. PubMed PMID: 15077403.
   PubMedGoogle Scholar
• Duffy P, Wolf J, Collins G, et al. Letter: possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med. 1974 Mar 21;290(12):692–693. PubMed PMID: 4591849.
   PubMed Web of Science ®Google Scholar
• Bernoulli C, Siegfried J, Baumgartner G, et al. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet. 1977 Feb 26;1(8009):478–479. PubMed PMID: 65575.
   PubMed Web of Science ®Google Scholar
• Gibbs CJ Jr., Joy A, Heffner R, et al. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med. 1985 Sep 19;313(12):734–738. PubMed PMID: 2863752.
   PubMed Web of Science ®Google Scholar
• From the Centers for Disease Control and Prevention. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts–Japan, January. 1979-May 1996. JAMA. 1998 Jan 7;279(1):11–12. PubMed PMID: 9424029.
   PubMedGoogle Scholar
• Williams D. New thoughts on CJD, surgical instruments and disease transmission. Med Device Technol. 2006 Jan-Feb;17(1):7–8. PubMed PMID: 16483102.
   PubMedGoogle Scholar
• Wallis JP. Variant CJD and blood transfusion. Vox Sang. 2015 May;108(4):432–433. PubMed PMID: 25753938.
   PubMed Web of Science ®Google Scholar
• Davidson LR, Llewelyn CA, Mackenzie JM, et al. Variant CJD and blood transfusion: are there additional cases? Vox Sang. 2014 Oct;107(3):220–225. PubMed PMID: 24916465.
   PubMed Web of Science ®Google Scholar
• Comoy EE, Mikol J, Jaffre N, et al. Experimental transfusion of variant CJD-infected blood reveals previously uncharacterised prion disorder in mice and macaque. Nat Commun. 2017 Nov 2;8(1):1268. 10.1038/s41467-017-01347-0. PubMed PMID: 29097653; PubMed Central PMCID: PMCPMC5668246.
   PubMedGoogle Scholar
• Urwin PJ, Mackenzie JM, Llewelyn CA, et al. Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study. Vox Sang. 2016 May;110(4):310–316. PubMed PMID: 26709606.
   PubMed Web of Science ®Google Scholar
• Yang H, Gregori L, Asher DM, et al. Risk assessment for transmission of variant Creutzfeldt-Jakob disease by transfusion of red blood cells in the United States. Transfusion. 2014 Sep;54(9):2194–2201. PubMed PMID: 24689837.
   PubMed Web of Science ®Google Scholar
• Turner ML, Ironside JW. New-variant Creutzfeldt-Jakob disease: the risk of transmission by blood transfusion. Blood Rev. 1998;Dec;12(4): 255–268. PubMed PMID: 9950096.
   PubMed Web of Science ®Google Scholar
• Diack AB, Head MW, McCutcheon S, et al. Variant CJD. 18 years of research and surveillance. Prion. 2014;8(4):286–295. PubMed PMID: 25495404; PubMed Central PMCID: PMCPMC4601215.
   PubMed Web of Science ®Google Scholar
• Bistaffa E, Rossi M, De Luca CMG, et al. Biosafety of Prions. Prog Mol Biol Transl Sci. 2017;150:455–485. PubMed PMID: 28838674.
   PubMed Web of Science ®Google Scholar
• Baskakov IV. The many shades of prion strain adaptation. Prion. 2014 Mar-Apr;8(2):169–172. PubMed PMID: 24518385; PubMed Central PMCID: PMCPMC4189885.
   Web of Science ®Google Scholar
• Legname G, Nguyen HO, Baskakov IV, et al. Strain-specified characteristics of mouse synthetic prions. Proc Natl Acad Sci U S A. 2005 Feb 08;102(6):2168–2173. PubMed PMID: 15671162; PubMed Central PMCID: PMCPMC548557.
   PubMed Web of Science ®Google Scholar
• Bistaffa E, Moda F, Virgilio T, et al. Synthetic prion selection and adaptation. Mol Neurobiol. 2018 Aug 3;56(4):2978–2989. doi: 10.1007/s12035-018-1279-2. PubMed PMID: 30074230.
   PubMed Web of Science ®Google Scholar
• Legname G, Nguyen HO, Peretz D, et al. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19105–19110. PubMed PMID: 17142317; PubMed Central PMCID: PMCPMC1748184.
   PubMed Web of Science ®Google Scholar
• Ghaemmaghami S, Watts JC, Nguyen HO, et al. Conformational transformation and selection of synthetic prion strains. J Mol Biol. 2011 Oct 28;413(3):527–542. PubMed PMID: 21839745; PubMed Central PMCID: PMCPMC3195964.
   PubMed Web of Science ®Google Scholar
• Moda F, Le TN, Aulic S, et al. Synthetic prions with novel strain-specified properties. PLoS Pathog. 2015 Dec;11(12):e1005354. PubMed PMID: 26720726; PubMed Central PMCID: PMCPMC4699842.
   PubMed Web of Science ®Google Scholar
• Li J, Browning S, Mahal SP, et al. Darwinian evolution of prions in cell culture. Science. 2010 Feb 12;327(5967):869–872. PubMed PMID: 20044542; PubMed Central PMCID: PMCPMC2848070.
   PubMed Web of Science ®Google Scholar
• Ghaemmaghami S, Ahn M, Lessard P, et al. Continuous quinacrine treatment results in the formation of drug-resistant prions. PLoS Pathog. 2009 Nov;5(11):e1000673. PubMed PMID: 19956709; PubMed Central PMCID: PMCPMC2777304.
   PubMed Web of Science ®Google Scholar
• Oelschlegel AM, Weissmann C. Acquisition of drug resistance and dependence by prions. PLoS Pathog. 2013 Feb;9(2):e1003158. PubMed PMID: 23408888; PubMed Central PMCID: PMCPMC3567182.
   PubMed Web of Science ®Google Scholar
• Chen B, Bruce KL, Newnam GP, et al. Genetic and epigenetic control of the efficiency and fidelity of cross-species prion transmission. Mol Microbiol. 2010 Jun;76(6):1483–1499. PubMed PMID: 20444092; PubMed Central PMCID: PMCPMC3025758.
   PubMed Web of Science ®Google Scholar
• Legname G, Moda F. The prion concept and synthetic prions. Prog Mol Biol Transl Sci. 2017;150:147–156. PubMed PMID: 28838659.
   PubMed Web of Science ®Google Scholar
• Kocisko DA, Baron GS, Rubenstein R, et al. New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J Virol. 2003 Oct;77(19):10288–10294. PubMed PMID: 12970413; PubMed Central PMCID: PMCPMC228499.
   PubMed Web of Science ®Google Scholar
• Kocisko DA, Engel AL, Harbuck K, et al. Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie. Neurosci Lett. 2005 Nov 11;388(2):106–111. PubMed PMID: 16039063.
   PubMed Web of Science ®Google Scholar
• Castilla J, Gonzalez-Romero D, Saa P, et al. Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell. 2008 Sep 5;134(5):757–768. PubMed PMID: 18775309; PubMed Central PMCID: PMCPMC2740631.
   PubMed Web of Science ®Google Scholar
• Green KM, Castilla J, Seward TS, et al. Accelerated high fidelity prion amplification within and across prion species barriers. PLoS Pathog. 2008 Aug 29;4(8):e1000139. PubMed PMID: 18769716; PubMed Central PMCID: PMCPMC2516356.
   PubMed Web of Science ®Google Scholar
• Meyerett C, Michel B, Pulford B, et al. In vitro strain adaptation of CWD prions by serial protein misfolding cyclic amplification. Virology. 2008 Dec 20;382(2):267–276. PubMed PMID: 18952250.
   PubMed Web of Science ®Google Scholar
• Katorcha E, Gonzalez-Montalban N, Makarava N, et al. Prion replication environment defines the fate of prion strain adaptation. PLoS Pathog. 2018 Jun;146:e1007093. PubMed PMID: 29928047; PubMed Central PMCID: PMCPMC6013019. company Trace-Ability, Inc. This company has no relationship to the current study. All the work performed by Nuria Gonzalez-Montalban for the current study was done while she was employed by the University of Maryland School of Medicine and funded by National Institute of Health Grants R01 NS045585. This does not alter our adherence to all PLOS policies on sharing data and materials.
   PubMed Web of Science ®Google Scholar
• Meyerett-Reid C, Wyckoff AC, Spraker T, et al. De Novo Generation of a unique cervid prion strain using protein misfolding cyclic amplification. mSphere. 2017 Jan-Feb;2(1). PubMed PMID: 28144628; PubMed Central PMCID: PMCPMC5266495. DOI:10.1128/mSphere.00372-16.
   PubMed Web of Science ®Google Scholar
• Sano K, Atarashi R, Ishibashi D, et al. Conformational properties of prion strains can be transmitted to recombinant prion protein fibrils in real-time quaking-induced conversion. J Virol. 2014 Oct;88(20):11791–11801. PubMed PMID: 25078700; PubMed Central PMCID: PMCPMC4178718.
   PubMed Web of Science ®Google Scholar
• Moda F. Protein misfolding cyclic amplification of infectious prions. Prog Mol Biol Transl Sci. 2017;150:361–374. PubMed PMID: 28838669.
   PubMed Web of Science ®Google Scholar
• Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature. 2001 Jun 14;411(6839):810–813. PubMed PMID: 11459061.
   PubMed Web of Science ®Google Scholar
• Shikiya RA, Eckland TE, Young AJ, et al. Prion formation, but not clearance, is supported by protein misfolding cyclic amplification. Prion. 2014;8(6):415–420. PubMed PMID: 25482601; PubMed Central PMCID: PMCPMC4601219.
   PubMed Web of Science ®Google Scholar
• Soto C, Saborio GP, Anderes L. Cyclic amplification of protein misfolding: application to prion-related disorders and beyond. Trends Neurosci. 2002 Aug;25(8):390–394. PubMed PMID: 12127750.
   PubMed Web of Science ®Google Scholar
• Morales R, Duran-Aniotz C, Diaz-Espinoza R, et al. Protein misfolding cyclic amplification of infectious prions. Nat Protoc. 2012 Jun 28;7(7):1397–1409. PubMed PMID: 22743831; PubMed Central PMCID: PMCPMC4049227.
   PubMed Web of Science ®Google Scholar
• Saunders SE, Bartz JC, Shikiya RA. Protein misfolding cyclic amplification of prions. J Vis Exp. 2012 Nov 7; (69). PubMed PMID: 23168797; PubMed Central PMCID: PMCPMC3520578. Doi:10.3791/4075.
   PubMed Web of Science ®Google Scholar
• Redaelli V, Bistaffa E, Zanusso G, et al. Detection of prion seeding activity in the olfactory mucosa of patients with Fatal Familial Insomnia. Sci Rep. 2017 Apr 7;7:46269. PubMed PMID: 28387370; PubMed Central PMCID: PMCPMC5384244.
   PubMed Web of Science ®Google Scholar
• Moda F, Gambetti P, Notari S, et al. Prions in the urine of patients with variant Creutzfeldt-Jakob disease. N Engl J Med. 2014 Aug 07;371(6):530–539. PubMed PMID: 25099577; PubMed Central PMCID: PMCPMC4162740.
   PubMed Web of Science ®Google Scholar
• Concha-Marambio L, Pritzkow S, Moda F, et al. Detection of prions in blood of variant Creutzfeldt-Jakob disease. In Sci Transl Med. 2016;8(370):370ra183. PMID:28003548.
   PubMed Web of Science ®Google Scholar
• Striebel JF, Race B, Meade-White KD, et al. Strain specific resistance to murine scrapie associated with a naturally occurring human prion protein polymorphism at residue 171. PLoS Pathog. 2011 Sep;7(9):e1002275. PubMed PMID: 21980292; PubMed Central PMCID: PMCPMC3182929.
   PubMed Web of Science ®Google Scholar
• Saa P, Sferrazza GF, Ottenberg G, et al. Strain-specific role of RNAs in prion replication. J Virol. 2012 Oct;86(19):10494–10504. PubMed PMID: 22811520; PubMed Central PMCID: PMCPMC3457318.
   PubMed Web of Science ®Google Scholar
• Shikiya RA, Langenfeld KA, Eckland TE, et al. PrPSc formation and clearance as determinants of prion tropism. PLoS Pathog. 2017 Mar;13(3):e1006298. PubMed PMID: 28355274; PubMed Central PMCID: PMCPMC5386299.
   PubMed Web of Science ®Google Scholar
• O’Connor MJ, Bishop K, Workman RG, et al. In vitro amplification of H-type atypical bovine spongiform encephalopathy by protein misfolding cyclic amplification. Prion. 2017 Jan 2;11(1):54–64. PubMed PMID: 28281929; PubMed Central PMCID: PMCPMC5360153.
   PubMed Web of Science ®Google Scholar
• Thorne L, Holder T, Ramsay A, et al. In vitro amplification of ovine prions from scrapie-infected sheep from Great Britain reveals distinct patterns of propagation. BMC Vet Res. 2012 Nov 15;8:223. PubMed PMID: 23153009; PubMed Central PMCID: PMCPMC3559253.
   PubMed Web of Science ®Google Scholar
• Bucalossi C, Cosseddu G, D’Agostino C, et al. Assessment of the genetic susceptibility of sheep to scrapie by protein misfolding cyclic amplification and comparison with experimental scrapie transmission studies. J Virol. 2011 Aug;85(16):8386–8392. PubMed PMID: 21680531; PubMed Central PMCID: PMCPMC3147950.
   PubMed Web of Science ®Google Scholar
• Johnson CJ, Aiken JM, McKenzie D, et al. Highly efficient amplification of chronic wasting disease agent by protein misfolding cyclic amplification with beads (PMCAb). PLoS One. 2012;7(4):e35383. PubMed PMID: 22514738; PubMed Central PMCID: PMCPMC3325955.
   PubMed Web of Science ®Google Scholar
• Cosseddu GM, Nonno R, Vaccari G, et al. Ultra-efficient PrP(Sc) amplification highlights potentialities and pitfalls of PMCA technology. PLoS Pathog. 2011 Nov;7(11):e1002370. PubMed PMID: 22114554; PubMed Central PMCID: PMCPMC3219717.
   PubMed Web of Science ®Google Scholar
• Saa P, Castilla J, Soto C. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem. 2006 Nov 17;281(46):35245–35252. PubMed PMID: 16982620.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Montalban N, Makarava N, Ostapchenko VG, et al. Highly efficient protein misfolding cyclic amplification. PLoS Pathog. 2011 Feb 10;7(2):e1001277. PubMed PMID: 21347353; PubMed Central PMCID: PMCPMC3037363.
   PubMed Web of Science ®Google Scholar
• Shikiya RA, Bartz JC. In vitro generation of high-titer prions. J Virol. 2011 Dec;85(24):13439–13442. PubMed PMID: 21957291; PubMed Central PMCID: PMCPMC3233131.
   PubMed Web of Science ®Google Scholar
• Bian J, Kang HE, Telling GC. Quinacrine promotes replication and conformational mutation of chronic wasting disease prions. Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):6028–6033. PubMed PMID: 24711410; PubMed Central PMCID: PMCPMC4000840.
   PubMed Web of Science ®Google Scholar
• Atarashi R, Wilham JM, Christensen L, et al. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods. 2008 Mar;5(3):211–212. PubMed PMID: 18309304.
   PubMed Web of Science ®Google Scholar
• Atarashi R, Satoh K, Sano K, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med. 2011 Feb;17(2):175–178. PubMed PMID: 21278748.
   PubMed Web of Science ®Google Scholar
• Wilham JM, Orru CD, Bessen RA, et al. Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog. 2010 Dec 2;6(12):e1001217. PubMed PMID: 21152012; PubMed Central PMCID: PMCPMC2996325.
   PubMed Web of Science ®Google Scholar
• Colby DW, Zhang Q, Wang S, et al. Prion detection by an amyloid seeding assay. Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20914–20919. PubMed PMID: 18096717; PubMed Central PMCID: PMCPMC2409241.
   PubMed Web of Science ®Google Scholar
• Caughey B, Orru CD, Groveman BR, et al. Amplified detection of prions and other amyloids by RT-QuIC in diagnostics and the evaluation of therapeutics and disinfectants. Prog Mol Biol Transl Sci. 2017;150:375–388. PubMed PMID: 28838670.
   PubMed Web of Science ®Google Scholar
• Orru CD, Groveman BR, Raymond LD, et al. Bank vole prion protein as an apparently universal substrate for RT-QuIC-based detection and discrimination of prion strains. PLoS Pathog. 2015 Jun;11(6):e1004983. PubMed PMID: 26086786; PubMed Central PMCID: PMCPMC4472236.
   PubMed Web of Science ®Google Scholar
• Masujin K, Orru CD, Miyazawa K, et al. Detection of atypical H-type bovine spongiform encephalopathy and discrimination of bovine prion strains by real-time quaking-induced conversion. J Clin Microbiol. 2016 Mar;54(3):676–686. PubMed PMID: 26739160; PubMed Central PMCID: PMCPMC4768002.
   PubMed Web of Science ®Google Scholar
• Schmitz M, Cramm M, Llorens F, et al. Application of an in vitro-amplification assay as a novel pre-screening test for compounds inhibiting the aggregation of prion protein scrapie. Sci Rep. 2016 Jul 7;6:28711. PubMed PMID: 27385410; PubMed Central PMCID: PMCPMC4935936.
   PubMed Web of Science ®Google Scholar
• Forloni G, Iussich S, Awan T, et al. Tetracyclines affect prion infectivity. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10849–10854. PubMed PMID: 12149459; PubMed Central PMCID: PMCPMC125061.
   PubMed Web of Science ®Google Scholar
• De Luigi A, Colombo L, Diomede L, et al. The efficacy of tetracyclines in peripheral and intracerebral prion infection. PLoS One. 2008 Mar 26;3(3):e1888. PubMed PMID: 18365024; PubMed Central PMCID: PMCPMC2268013.
   PubMed Web of Science ®Google Scholar
• Hyeon JW, Kim SY, Lee SM, et al. Anti-prion screening for acridine, dextran, and tannic acid using real time-quaking induced conversion: a comparison with PrPSc-infected cell screening. PLoS One. 2017;12(1):e0170266. PubMed PMID: 28095474; PubMed Central PMCID: PMCPMC5240994.
   PubMed Web of Science ®Google Scholar
• Kondru N, Manne S, Greenlee J, et al. Integrated organotypic slice cultures and RT-QuIC (OSCAR) assay: implications for translational discovery in protein misfolding diseases. Sci Rep. 2017 Feb 24;7:43155. PubMed PMID: 28233859; PubMed Central PMCID: PMCPMC5324099.
   PubMed Web of Science ®Google Scholar
• Gandini A, Bolognesi ML. Therapeutic approaches to prion diseases. Prog Mol Biol Transl Sci. 2017;150:433–453. PubMed PMID: 28838673.
   PubMed Web of Science ®Google Scholar
• Teruya K, Doh-Ura K. Insights from therapeutic studies for PrP Prion disease. Cold Spring Harb Perspect Med. 2017 Mar 1;7(3):a024430. PubMed PMID: 27836910; PubMed Central PMCID: PMCPMC5334251. .
   PubMed Web of Science ®Google Scholar
• Tornqvist E, Annas A, Granath B, et al. Strategic focus on 3R principles reveals major reductions in the use of animals in pharmaceutical toxicity testing. PLoS One. 2014;9(7):e101638. PubMed PMID: 25054864; PubMed Central PMCID: PMCPMC4108312.
   PubMed Web of Science ®Google Scholar
• Ghaemmaghami S, Russo M, Renslo AR. Successes and challenges in phenotype-based lead discovery for prion diseases. J Med Chem. 2014 Aug 28;57(16):6919–6929. PubMed PMID: 24762293; PubMed Central PMCID: PMCPMC4148153. .
   PubMed Web of Science ®Google Scholar
• Lafon PA, Imberdis T, Wang Y, et al. Low doses of bioherbicide favour prion aggregation and propagation in vivo. Sci Rep. 2018 May 23;8(1):8023. 10.1038/s41598-018-25966-9. PubMed PMID: 29795181; PubMed Central PMCID: PMCPMC5966510.
   PubMedGoogle Scholar
• Imberdis T, Ayrolles-Torro A, Duarte Rodrigues A, et al. A fluorescent oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases. Mol Neurodegener. 2016 Jan 26;11:11. 10.1186/s13024-016-0074-7. PubMed PMID: 26809712; PubMed Central PMCID: PMCPMC4727337.
   PubMed Web of Science ®Google Scholar
• Ladner-Keay CL, Ross L, Perez-Pineiro R, et al. A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds. Prion. 2018;12(5–6):280–300. PubMed PMID: 30223704; PubMed Central PMCID: PMCPMC6277192.
   PubMed Web of Science ®Google Scholar
• Bolognesi ML, Legname G. Approaches for discovering anti-prion compounds: lessons learned and challenges ahead. Expert Opin Drug Discov. 2015 Apr;10(4):389–397. PubMed PMID: 25682812.
   PubMed Web of Science ®Google Scholar
• Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004 Aug;3(8):673–683. PubMed PMID: 15286734.
   PubMed Web of Science ®Google Scholar
• Corsello SM, Bittker JA, Liu Z, et al. The drug repurposing Hub: a next-generation drug library and information resource. Nat Med. 2017 Apr 7;23(4):405–408. PubMed PMID: 28388612; PubMed Central PMCID: PMCPMC5568558.
   PubMed Web of Science ®Google Scholar
• Janes J, Young ME, Chen E, et al. The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis. Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10750–10755. PubMed PMID: 30282735; PubMed Central PMCID: PMCPMC6196526.
   PubMed Web of Science ®Google Scholar
• Shahnawaz M, Tokuda T, Waragai M, et al. Development of a biochemical diagnosis of parkinson disease by detection of alpha-synuclein misfolded aggregates in cerebrospinal fluid. JAMA Neurol. 2017 Feb 1;74(2):163–172. PubMed PMID: 27918765.
   PubMed Web of Science ®Google Scholar
• Fairfoul G, McGuire LI, Pal S, et al. Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann Clin Transl Neurol. 2016 Oct;3(10):812–818. PubMed PMID: 27752516; PubMed Central PMCID: PMCPMC5048391.
   PubMed Web of Science ®Google Scholar
• Groveman BR, Orru CD, Hughson AG, et al. Rapid and ultra-sensitive quantitation of disease-associated alpha-synuclein seeds in brain and cerebrospinal fluid by alphaSyn RT-QuIC. Acta Neuropathol Commun. 2018 Feb 9;6(1):7. 10.1186/s40478-018-0508-2. PubMed PMID: 29422107; PubMed Central PMCID: PMCPMC5806364.
   PubMedGoogle Scholar
• Saijo E, Groveman BR, Kraus A, et al. Ultrasensitive RT-QuIC seed amplification assays for disease-associated Tau, alpha-Synuclein, and Prion Aggregates. Methods Mol Biol. 2019;1873:19–37. PubMed PMID: 30341601.
   PubMedGoogle Scholar
• Sano K, Atarashi R, Satoh K, et al. Prion-like seeding of misfolded alpha-Synuclein in the brains of dementia with lewy body patients in RT-QUIC. Mol Neurobiol. 2018 May;55(5):3916–3930. 10.1007/s12035-017-0624-1. PubMed PMID: 28550528; PubMed Central PMCID: PMCPMC5884914.
   PubMed Web of Science ®Google Scholar